Report cover image

NA Laboratory-Developed Tests (LDTs) Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published Jun 01, 2023
Length 275 Pages
SKU # DAABD18055198

Description

NA Laboratory-Developed Tests (LDTs) Market - Industry Trends and Forecast to 2030


The North America Laboratory-Developed Tests (LDTs) Market is expected to reach USD 17,680.85 Million by 2030 from USD 6,901.04 Million in 2022, growing at a CAGR of 12.5% during the forecast period of 2023 to 2030.

Market Segmentation

North America Laboratory-Developed Tests (LDTs) Market, By Test Type (Clinical Chemistry and Immunology, Critical Care, Hematology, Molecular Diagnostics, Microbiology, and Other Test), Product Type (Consumables, Analyzers and Instruments, and Accessories), Sample Type (Blood, Urine, Tissue, Cerebrospinal Fluid (CSF), and Others), Therapeutic Area (Infections, Genetic Disorders, Oncology/Cancer, Autoimmune Disease, Urology, Gynecology, and Others), Gender (Male, and Female), Age Group (Geriatrics, Adult, and Pediatric), End Users (Hospital-Based Labs, Stand-Alone Labs, Diagnostic Chains, Academic Institutes, Clinical Research Organizations, Specialty Diagnostic Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors, and Others), Country (U.S., Canada, Mexico) - Industry Trends and Forecast to 2030

Overview of North America Laboratory-Developed Tests (LDTs) Market Dynamics

Drivers

• Increasing demand for personalized medicines
• Advancements in molecular diagnostics

Restraint

• Stringent quality control and standardization for LDTs
Opportunity

• Increasing demand for precision medicine and targeted therapy

Market Players
Some of the major market players operating in the North America Laboratory-Developed Tests (LDTs) market are:
• F. Hoffmann-La Roche Ltd
• bioMérieux, Inc.
• Sysmex Corporation
• Biomerica, Inc.
• Bio-Rad Laboratories, Inc.
• Abbott
• Siemens Medical Solutions USA, Inc.
• Quest Diagnostics Incorporated
• QIAGEN
• Eurofins Scientific
• Biodesix.
• Hologic, Inc.
• Guardant Health
• OPKO Health, Inc.
• BD
• Beckman Coulter, Inc.
• NeoGenomics Laboratories.
• Seegene Inc.
• Ambry Genetics
• BGI
• 23andMe, Inc.
• Admera Health
• Agendia

Table of Contents

275 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Laboratory-developed Tests (Ldts) Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Test Type Segment Lifeline Curve
2.8 Market End User Coverage Grid
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter's Five Forces Model
5 Industry Insights
6 Number Of Labs
6.1 Number Of Labs In Middle Eastern Countries
6.2 Number Of Labs In Europe
7 Regulations Of The North America Laboratory-developed Tests (Ldts) Market
7.1 U.S.
8 Market Overview
8.1 Drivers
8.1.1 Increasing Demand For Personalized Medicine
8.1.2 Advancements In Molecular Diagnostics
8.1.3 Growing Prevalence Of Chronic Diseases
8.1.4 Increasing Awareness And Acceptance Towards The Assistances Of Ldts
8.2 Restraints
8.2.1 Stringent Quality Control And Standardization For Ldts
8.2.2 Strict Regulatory Guidelines Regarding Ldts
8.3 Opportunities
8.3.1 Increasing Demand For Precision Medicine And Targeted Therapy
8.3.2 Enhanced Healthcare Substructure
8.4 Challenges
8.4.1 Deprived Data Interpretation And Integration
8.4.2 Complex Laboratory Processes
9 North America Laboratory-developed Tests (Ldts) Market, By Test Type
9.1 Overview
9.2 Clinical Chemistry And Immunology
9.2.1 Glucose
9.2.1.1 Glucose Challenge Test
9.2.1.2 Oral Glucose Tolerance Test (Ogtt)
9.2.2 Prothrombin
9.2.3 Metabolic Panel
9.2.3.1 Basic
9.2.3.2 Comprehensive
9.2.4 Lipid Panel
9.2.5 Liver Panel
9.2.5.1 Alp Test (Alkaline Phosphate)
9.2.5.2 Alt Test (Alkaline Transminase)
9.2.5.3 Ast Test (Aspartate Aminotransferase)
9.2.5.4 Gamma-glutamyl Transferase (Ggt) Test
9.2.6 Thyroid Stimulating Hormone
9.2.7 Urinalysis
9.2.7.1 Red Blood Cell Urine Test
9.2.7.2 Glucose Urine Test
9.2.7.3 Protein Urine Test
9.2.7.4 Urine Ph Level
9.2.7.5 Ketones Urine Test
9.2.7.6 Biliburin Urine Test
9.2.7.7 Urine Specific Gravity Test
9.2.8 Others
9.3 Critical Care
9.3.1 Carboxyhaemoglobin Test
9.3.2 Ph Test
9.3.3 Potassium Test
9.3.4 Sodium Test
9.3.5 Methemoglobin Test
9.3.6 Lactate Test
9.3.7 Others
9.4 Haematology
9.4.1 Complete Blood Count (Cbc)
9.4.1.1 White Blood Cell Count (Wbc)
9.4.1.2 Red Blood Cell Count (Rbc)
9.4.2 Platelet Count
9.4.3 Blood Protein Testing
9.4.4 Others
9.5 Molecular Diagnostic
9.5.1 Sample Type
9.5.1.1 Blood
9.5.1.2 Urine
9.5.1.3 Tissue
9.5.1.4 Cerebrospinal Fluid (Csf)
9.5.1.5 Others
9.5.2 Therapeutic Area
9.5.2.1 Infections
9.5.2.2 Genetic Disorders
9.5.2.3 Oncology/Cancer
9.5.2.4 Autoimmune Disease
9.5.2.5 Urology
9.5.2.6 Gynecology
9.5.2.7 Others
9.5.3 Technology
9.5.3.1 Polymerase Chain Reaction (Pcr)
9.5.3.2 Next-generation Sequencing (Ngs)
9.5.3.3 Fluorescence In Situ Hybridization (Fish)
9.5.3.4 Sanger Sequencing
9.5.3.5 Microarrays
9.5.3.6 Mass Spectrometry
9.5.3.7 Isothermal Amplification
9.5.4 End User
9.5.4.1 Hospital-based Labs
9.5.4.2 Stand-alone Labs
9.5.4.3 Diagnostic Chains
9.5.4.4 Academic Institutes
9.5.4.5 Clinical Research Organizations
9.5.4.6 Specialty Diagnostic Centers
9.5.4.7 Others
9.6 Microbiology
9.6.1 Microscopy
9.6.2 Culture
9.6.3 Antimicrobial Susceptibility Test
9.6.4 Others
9.7 Other Test
9.7.1 Drugs Of Abuse Testing
9.7.2 Hepatitis
9.7.3 Human Immunodeficiency Viruses (Hiv)
9.7.4 Malaria
9.7.5 Tuberculosis
9.7.6 Human Papillomavirus (Hpv)
9.7.7 Others
10 North America Laboratory-developed Tests (Ldts) Market, By Product Type
10.1 Overview
10.2 Consumables
10.2.1 Panels
10.2.2 Reagent And Kits
10.2.3 Others
10.3 Analyzers And Instruments
10.3.1 Fully-automated Instruments
10.3.2 Semi-automated Instruments
10.3.3 Others
10.4 Accessories
11 North America Laboratory-developed Tests (Ldts) Market, By Sample Type
11.1 Overview
11.2 Blood
11.3 Urine
11.4 Tissue
11.5 Cerebrospinal Fluid (Csf)
11.6 Others
12 North America Laboratory-developed Tests (Ldts) Market, By Therapeutic Area
12.1 Overview
12.2 Infections
12.2.1 Methicillin-resistant Staphylococcus Aureus (Mrsa)
12.2.2 Clostridium Difficile
12.2.3 Vancomycin-resistant Enterococci (Vre)
12.2.4 Carbapenem-resistant Bacteria
12.2.5 Flu
12.2.6 Respiratory Syncytial Virus (Rsv)
12.2.7 Candida
12.2.8 Tuberculosis And Drug-resistant Tba
12.2.9 Meningitis
12.2.10 Gastrointestinal Panel Testing
12.2.11 Chlamydia
12.2.12 Gonorrhea
12.2.13 Hiv
12.2.14 Hepatitis B
12.2.15 Hepatitis C
12.2.16 Other Infectious Diseases
12.3 Genetic Disorders
12.3.1 New Born Screening
12.3.2 Predictive And Presymptomatic Testing
12.3.3 Other Genetic Testing
12.4 Oncology/Cancer
12.4.1 Breast Cancer
12.4.2 Prostate Cancer
12.4.3 Colorectal Cancer
12.4.4 Cervical Cancer
12.4.5 Kidney Cancer
12.4.6 Liver Cancer
12.4.7 Blood Cancer
12.4.8 Lung Cancer
12.4.9 Other Cancer
12.5 Autoimmune Disease
12.6 Urology
12.7 Gynecology
12.8 Others
13 North America Laboratory-developed Tests (Ldts) Market, By Gender
13.1 Overview
13.2 Male
13.3 Female
14 North America Laboratory-developed Tests (Ldts) Market, By Age Group
14.1 Overview
14.2 Geriatrics
14.3 Adult
14.4 Pediatrics
15 North America Laboratory-developed Tests (Ldts) Market, By End User
15.1 Overview
15.2 Hospital-based Labs
15.3 Stand –alone Labs
15.4 Diagnostic Chains
15.5 Academic Institutes
15.6 Clinical Research Organistaion
15.7 Specialty Diagnostic
15.8 Others
16 North America Laboratory-developed Tests (Ldts) Market, By Distribution Channel
16.1 Overview
16.2 Direct Tender
16.3 Retail Sales
16.4 Third Party Distributors
16.5 Others
17 North America Laboratory-developed Tests (Ldts) Market, By Region
17.1 North America
17.1.1 U.S.
17.1.2 Canada
17.1.3 Mexico
18 North America Laboratory-developed Tests (Ldts) Market, Company Landscape
18.1 Company Share Analysis: North America
19 Company Profiles
19.1 F. Hoffmann-la Roche Ltd.
19.1.1 Company Snapshot
19.1.2 Revenue Analysis
19.1.3 Company Share Analysis
19.1.4 Product Portfolio
19.1.5 Recent Development
19.2 Biomérieux
19.2.1 Company Snapshot
19.2.2 Revenue Analysis
19.2.3 Company Share Analysis
19.2.4 Product Portfolio
19.2.5 Recent Developments
19.3 Sysmex Corporation
19.3.1 Company Snapshot
19.3.2 Revenue Analysis
19.3.3 Company Share Analysis
19.3.4 Product Portfolio
19.3.5 Recent Development
19.4 Biomerica.
19.4.1 Company Snapshot
19.4.2 Revenue Analysis
19.4.3 Company Share Analysis
19.4.4 Product Portfolio
19.4.5 Recent Development
19.5 Bio-rad Laboratories, Inc
19.5.1 Company Snapshot
19.5.2 Revenue Analysis
19.5.3 Company Share Analysis
19.5.4 Product Portfolio
19.5.5 Recent Development
19.6 23andme, Inc.
19.6.1 Company Snapshot
19.6.2 Revenue Analysis
19.6.3 Product Portfolio
19.6.4 Recent Developments
List Of Tables
Table 1 Number Of Genetic Testing Laboratories In Eu
Table 2 North America Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 3 North America Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 4 North America Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 5 North America Glucose In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million))
Table 6 North America Metabolic Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 7 North America Liver Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 8 North America Urinalysis In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 9 North America Critical Care In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 10 North America Critical Care In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million))
Table 11 North America Haematology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 12 North America Haematology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)))
Table 13 North America Complete Blood Count (Cbc) In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 14 North America Molecular Diagnostic In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 15 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 16 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 17 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Technology, 2021-2030 (Usd Million)
Table 18 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 19 North America Microbiology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 20 North America Microbiology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million))
Table 21 North America Other Test In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 22 North America Other Test In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 23 North America Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 24 North America Consumables In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 25 North America Consumables In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 26 North America Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 27 North America Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 28 North America Accessories In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 29 North America Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 30 North America Blood In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 31 North America Urine In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 32 North America Tissue In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 33 North America Cerebrospinal Fluid (Csf) In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 34 North America Others In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 35 North America Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 36 North America Infections In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 37 North America Infections In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 38 North America Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 39 North America Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 40 North America Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 41 North America Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 42 North America Autoimmune Disease In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 43 North America Urology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 44 North America Gynecology In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 45 North America Others In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 46 North America Laboratory-developed Tests (Ldts) Market, By Gender, 2021-2030 (Usd Million)
Table 47 North America Male In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 48 North America Female In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 49 North America Laboratory-developed Tests (Ldts) Market, By Age Group, 2021-2030 (Usd Million)
Table 50 North America Geriatrics In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 51 North America Adult In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 52 North America Pediatrics In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 53 North America Laboratory-developed Tests (Ldts) Market, By End User, 2021-2030 (Usd Million)
Table 54 North America Hospital-based Lab In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 55 North America Stand- Alone Labs In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 56 North America Diagnostic Chains In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 57 North America Academic Institutes In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 58 North America Clinical Research Organisation In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 59 North America Specialty Diagnostic In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 60 North America Others In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 61 North America Laboratory-developed Tests (Ldts) Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 62 North America Direct Tender In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 63 North America Retail Sales In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 64 North America Direct Tender In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 65 North America Others In Laboratory-developed Tests (Ldts) Market, By Region, 2021-2030 (Usd Million)
Table 66 North America Laboratory-developed Tests (Ldts) Market, By Country, 2021-2030 (Usd Million)
Table 67 North America Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 68 North America Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 69 North America Glucose In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 70 North America Metabolic Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 71 North America Liver Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 72 North America Urinalysis In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 73 North America Critical Care In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 74 North America Haematology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 75 North America Complete Blood Count (Cbc) In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 76 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 77 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 78 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Technology, 2021-2030 (Usd Million)
Table 79 North America Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 80 North America Microbiology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 81 North America Other Test In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 82 North America Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 83 North America Consumables In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 84 North America Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 85 North America Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 86 North America Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 87 North America Infections In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 88 North America Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 89 North America Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 90 North America Laboratory-developed Tests (Ldts) Market, By Gender, 2021-2030 (Usd Million)
Table 91 North America Laboratory-developed Tests (Ldts) Market, By Age Group, 2021-2030 (Usd Million)
Table 92 North America Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 93 North America Laboratory-developed Tests (Ldts) Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 94 U.S. Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 95 U.S. Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 96 U.S. Glucose In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 97 U.S. Metabolic Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 98 U.S. Liver Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 99 U.S. Urinalysis In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 100 U.S. Critical Care In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 101 U.S. Haematology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 102 U.S. Complete Blood Count (Cbc) In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 103 U.S. Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 104 U.S. Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 105 U.S. Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Technology, 2021-2030 (Usd Million)
Table 106 U.S. Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 107 U.S. Microbiology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 108 U.S. Other Test In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 109 U.S. Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 110 U.S. Consumables In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 111 U.S. Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 112 U.S. Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 113 U.S. Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 114 U.S. Infections In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 115 U.S. Genetic Disorders In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 116 U.S. Oncology/Cancer In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 117 U.S. Laboratory-developed Tests (Ldts) Market, By Gender, 2021-2030 (Usd Million)
Table 118 U.S. Laboratory-developed Tests (Ldts) Market, By Age Group, 2021-2030 (Usd Million)
Table 119 U.S. Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 120 U.S. Laboratory-developed Tests (Ldts) Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 121 Canada Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 122 Canada Clinical Chemistry And Immunology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 123 Canada Glucose In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 124 Canada Metabolic Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 125 Canada Liver Panel In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 126 Canada Urinalysis In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 127 Canada Critical Care In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 128 Canada Haematology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 129 Canada Complete Blood Count (Cbc) In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 130 Canada Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 131 Canada Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 132 Canada Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By Technology, 2021-2030 (Usd Million)
Table 133 Canada Molecular Diagnostics In Laboratory-developed Tests (Ldts) Market, By End Users, 2021-2030 (Usd Million)
Table 134 Canada Microbiology In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 135 Canada Other Test In Laboratory-developed Tests (Ldts) Market, By Test Type, 2021-2030 (Usd Million)
Table 136 Canada Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 137 Canada Consumables In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 138 Canada Analyzers And Instruments In Laboratory-developed Tests (Ldts) Market, By Product Type, 2021-2030 (Usd Million)
Table 139 Canada Laboratory-developed Tests (Ldts) Market, By Sample Type, 2021-2030 (Usd Million)
Table 140 Canada Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 141 Canada Infections In Laboratory-developed Tests (Ldts) Market, By Therapeutic Area, 2021-2030 (Usd Million)
List Of Figures
Figure 1 North America Laboratory-developed Tests (Ldts) Market: Segmentation
Figure 2 North America Laboratory-developed Tests (Ldts) Market: Data Triangulation
Figure 3 North America Laboratory-developed Tests (Ldts) Market: Droc Analysis
Figure 4 North America Laboratory-developed Tests (Ldts) Market: North America Vs Regional Market Analysis
Figure 5 North America Laboratory-developed Tests (Ldts) Market: Company Research Analysis
Figure 6 North America Laboratory-developed Tests (Ldts) Market: Interview Demographics
Figure 7 North America Laboratory-developed Tests (Ldts) Market: Market End User Coverage Grid
Figure 8 North America Laboratory-developed Tests (Ldts) Market: Dbmr Market Position Grid
Figure 9 North America Laboratory-developed Tests (Ldts) Market: Vendor Share Analysis
Figure 10 North America Laboratory-developed Tests (Ldts) Market: Segmentation
Figure 11 Rising Demand For Personalized Medicines And Advancements In Molecular Diagnostics Are Expected To Drive The Growth Of The North America Laboratory-developed Tests (Ldts) Market From 2023 To 2030
Figure 12 The Clinical Chemistry And Immunology Segment Is Expected To Account For The Largest Share Of The North America Laboratory-developed Tests (Ldts) Market In 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities And Challenges Of The North America Laboratory-developed Tests (Ldts) Market
Figure 14 North America Laboratory-developed Tests (Ldts) Market: By Test Type, 2022
Figure 15 North America Laboratory-developed Tests (Ldts) Market: By Test Type, 2023-2030 (Usd Million)
Figure 16 North America Laboratory-developed Tests (Ldts) Market: By Test Type, Cagr (2023-2030)
Figure 17 North America Laboratory-developed Tests (Ldts) Market: By Test Type, Lifeline Curve
Figure 18 North America Laboratory-developed Tests (Ldts) Market: By Product Type, 2022
Figure 19 North America Laboratory-developed Tests (Ldts) Market: By Product Type, 2023-2030 (Usd Million)
Figure 20 North America Laboratory-developed Tests (Ldts) Market: By Product Type, Cagr (2023-2030)
Figure 21 North America Laboratory-developed Tests (Ldts) Market: By Product Type, Lifeline Curve
Figure 22 North America Laboratory-developed Tests (Ldts) Market: By Sample Type, 2022
Figure 23 North America Laboratory-developed Tests (Ldts) Market: By Sample Type, 2023-2030 (Usd Million)
Figure 24 North America Laboratory-developed Tests (Ldts) Market: By Sample Type, Cagr (2023-2030)
Figure 25 North America Laboratory-developed Tests (Ldts) Market: By Sample Type, Lifeline Curve
Figure 26 North America Laboratory-developed Tests (Ldts) Market: By Therapeutic Area, 2022
Figure 27 North America Laboratory-developed Tests (Ldts) Market: By Therapeutic Area, 2020-2029 (Usd Million)
Figure 28 North America Laboratory-developed Tests (Ldts) Market: By Therapeutic Area, Cagr (2023-2030)
Figure 29 North America Laboratory-developed Tests (Ldts) Market: By Therapeutic Area, Lifeline Curve
Figure 30 North America Laboratory-developed Tests (Ldts) Market: By Gender, 2022
Figure 31 North America Laboratory-developed Tests (Ldts) Market: By Gender, 2023-2030 (Usd Million)
Figure 32 North America Laboratory-developed Tests (Ldts) Market: By Gender, Cagr (2023-2030)
Figure 33 North America Laboratory-developed Tests (Ldts) Market: By Gender, Lifeline Curve
Figure 34 North America Laboratory-developed Tests (Ldts) Market: By Age Group, 2022
Figure 35 North America Laboratory-developed Tests (Ldts) Market: By Age Group, 2023-2030 (Usd Million)
Figure 36 North America Laboratory-developed Tests (Ldts) Market: By Age Group, Cagr (2023-2030)
Figure 37 North America Laboratory-developed Tests (Ldts) Market: By Age Group, Lifeline Curve
Figure 38 North America Laboratory-developed Tests (Ldts) Market: By End User, 2022
Figure 39 North America Laboratory-developed Tests (Ldts) Market: By End User, 2023-2030 (Usd Million)
Figure 40 North America Laboratory-developed Tests (Ldts) Market: By End User, Cagr (2023-2030)
Figure 41 North America Laboratory-developed Tests (Ldts) Market: By End User, Lifeline Curve
Figure 42 North America Laboratory-developed Tests (Ldts) Market: By Distribution Channel, 2022
Figure 43 North America Laboratory-developed Tests (Ldts) Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 44 North America Laboratory-developed Tests (Ldts) Market: By Distribution Channel, Cagr (2023-2030)
Figure 45 North America Laboratory-developed Tests (Ldts) Market: By Distribution Channel, Lifeline Curve
Figure 46 North America Laboratory-developed Tests (Ldts) Market: Snapshot (2022)
Figure 47 North America Laboratory-developed Tests (Ldts) Market: By Country (2022)
Figure 48 North America Laboratory-developed Tests (Ldts) Market: By Country (2023 & 2030)
Figure 49 North America Laboratory-developed Tests (Ldts) Market: By Country (2022 & 2030)
Figure 50 North America Laboratory-developed Tests (Ldts) Market: By Test Type (2023-2030)
Figure 51 North America Laboratory-developed Tests (Ldts) Market: Company Share 2022 (%) 184

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us